Renovis
AcquiredSouth San Francisco, United States · Founded 2000 · $45.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2000
- Business Model
- B2B
- Total Funding
- $45.0M
- Last Round
- $45.0M Venture RoundJan 2007
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Renovis, Inc. was a biopharmaceutical company founded in 2000 by UC Berkeley and UCSF faculty—including neuroscientist Corey Goodman—focused on discovering and developing small molecule drugs to treat neurological diseases and disorders. The company applied molecular biology, medicinal chemistry, in vitro and in vivo pharmacology, drug metabolism, and informatics to identify drug candidates targeting purinergic receptors (P2X3 and P2X7) for the potential treatment of pain and inflammatory conditions. Renovis was acquired by Evotec AG in 2008 in a $152 million stock deal.
Summary
Renovis is a Biotech company based in South San Francisco, United States, founded in 2000. It has raised $45.0M in total across 2 rounds, most recently a $45.0M Venture Round in Jan 2007. Investors include Alta Partners, Venrock and Flagship Pioneering.
Funding History
2007 (est.)
Sign up to see all 2 events
Funding: Series A through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/renovis"><img src="https://indexed.vc/api/badge/company/renovis" alt="Renovis on Indexed.vc" width="260" height="76" /></a>